8-K - Lycia Therapeutics, Inc. (0001806540) (Filer)
Published . Updated .
8-K - Lycia Therapeutics filed an 8-K with the SEC on Oct 26 (a notice of a material company event).
Directly affected
- LYCA Lycia Therapeutics
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LYCANo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-26 AccNo: 0001628280-26-067312 Size: 443 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How solid “8-K - Lycia Therapeutics, Inc. (0001806540) (Filer)” looks
12 out of 100
“8-K - Lycia Therapeutics, Inc. (0001806540) (Filer)” scores 12 out of 100. The score uses 1 sources.